A detailed history of Mesirow Financial Investment Management, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 6,448 shares of VCEL stock, worth $372,436. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,448
Holding current value
$372,436
% of portfolio
0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$42.25 - $53.56 $272,428 - $345,354
6,448 New
6,448 $272,000
Q2 2024

Jul 16, 2024

BUY
$41.71 - $52.9 $326,881 - $414,577
7,837 New
7,837 $360 Million
Q1 2024

Apr 19, 2024

SELL
$32.52 - $52.33 $75,348 - $121,248
-2,317 Reduced 22.86%
7,820 $407 Million
Q2 2023

Jul 14, 2023

SELL
$29.0 - $38.37 $15,051 - $19,914
-519 Reduced 4.87%
10,137 $380,000
Q2 2022

Jul 20, 2022

SELL
$22.88 - $39.45 $663 - $1,144
-29 Reduced 0.27%
10,656 $268,000
Q1 2022

May 02, 2022

BUY
$31.69 - $43.29 $919 - $1,255
29 Added 0.27%
10,685 $408,000
Q3 2021

Oct 20, 2021

SELL
$46.35 - $59.75 $14,183 - $18,283
-306 Reduced 2.79%
10,656 $520,000
Q2 2021

Jul 23, 2021

SELL
$47.2 - $67.81 $107,332 - $154,199
-2,274 Reduced 17.18%
10,962 $576,000
Q1 2021

Apr 14, 2021

SELL
$30.93 - $59.48 $252,667 - $485,892
-8,169 Reduced 38.16%
13,236 $735,000
Q4 2020

Jan 14, 2021

SELL
$18.53 - $31.5 $40,450 - $68,764
-2,183 Reduced 9.25%
21,405 $660,000
Q3 2020

Oct 13, 2020

BUY
$14.68 - $19.12 $49,633 - $64,644
3,381 Added 16.73%
23,588 $437,000
Q2 2020

Jul 22, 2020

SELL
$8.5 - $15.82 $58,667 - $109,189
-6,902 Reduced 25.46%
20,207 $279,000
Q1 2020

Apr 09, 2020

BUY
$7.25 - $19.22 $196,540 - $521,034
27,109 New
27,109 $249,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.73B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.